Prestige Consumer Healthcare Inc. · NYSE:PBH
Prestige Consumer Healthcare — Prestige Brands Holdings — Q3 FY2014 Earnings Presentation
28 slides from Prestige Consumer Healthcare's earnings presentation, Feb 6, 2014
Slide 1: Review of Third Quarter F'14 Results
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 Review of Third Quarter F’14 Results Matt Mannelly, CEO & President Ron Lombardi, CFO February 6, 2014 Exhibit 99.2
Slide 2: Safe Harbor Disclosure
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 This presentation contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company’s growth strategies, investments in marketing,
Slide 3: Agenda for Today's Discussion
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 3 1. Perspective on Current Environment 2. Q3 FY2014: Performance Highlights 3. Q3 FY2014: Financial Overview 4. FY2014 Outlook and The Road Ahead Agenda for Today’s Discussion
Slide 4: Perspective on Current Environment
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 4 Perspective on Current Environment
Slide 5: Current Environment
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 5 Current Environment Anticipated near-term transitional marketplace…combination of factors resulted in significant impact − Soft retail foot traffic has led to significant retail inventory reductions − Returning competitive
Slide 6: Three Primary Environmental Factors Are Impacting Current and Near-Term Performance
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 6 Three Primary Environmental Factors Are Impacting Current and Near-Term Performance Retailer Dynamics Pediatric Product Returns Cough/Cold & Other Category Dynamics(2) “We continue to see a cautious consumer. We did see some
Slide 7: Q3 FY2014: Performance Highlights
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 7 Q3 FY2014: Performance Highlights
Slide 8: Third Quarter Performance Highlights
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 8 Third Quarter Performance Highlights Q3 Performance Highlights − Strong Free Cash Flow of $41.2(1) million, up 11.8% versus the prior year − Q3 consolidated net revenue of $146.2 million was down 8.7% versus the prior year
Slide 9: Q3 Results Impacted by Combination of Events
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 9 Q3 Results Impacted by Combination of Events Sources of Y/Y Net Revenue Decline Retail Inventory Reductions Competitive Product Returns Other Cough/Cold & GI Category Dynamics Greater than anticipated trade inventory reduc
Slide 10: Impact of Retail Inventory Reductions Concentrated in the Mass Channel
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 0 Impact of Retail Inventory Reductions Concentrated in the Mass Channel Consolidated Total Revenue Growth Note: Represents year-over-year Revenue growth. (1) These Non-GAAP financial measures are reconciled to their most cl
Slide 11: Core OTC Consumption Growth Outpacing Reported Revenue Growth
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 1 Core OTC Consumption Growth Outpacing Reported Revenue Growth Due to Retailer Dynamics Source: Latest 12-week IRI multi-outlet retail dollar sales growth for relevant quarter. Note: Data reflects retail dollar sales percen
Slide 12: "It's A Marathon Not A Sprint": Long-Term Brand Building Strategies
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 2 “It’s A Marathon Not A Sprint”, Maintain Emphasis on Appropriate Long-Term Brand Building Strategies Sustained Long-Term Growth & Share Gains Innovative New Products Increased Marketing Support and Effectiveness Increased
Slide 13: Transitional Market: Remain Focused on Drivers of Growth Over Time
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 3 Transitional Market Remain Focused on Drivers of Growth Over Time Core OTC Consumption Growth Source: Latest 12-week IRI multi-outlet retail dollar sales growth for relevant quarter. Note: Data reflects retail dollar sales
Slide 14: Introducing New Fresh Guard by Efferdent
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 4 Gain Professional Endorsement Introducing New Fresh Guard by Efferdent New Fresh Guard Addresses Unmet Consumer Needs Kills 99.9% of odor causing bacteria Specially formulated for removable dental appliances Preven
Slide 15: Continue to Invest Appropriately Behind Brand Building
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 5 Continue to Invest Appropriately Behind Brand Building to Support Long-Term Growth (1) (1) Adjusted in FY’11 to reflect normalized level of A&P spending for PediaCare. A&P % of Net Revenue
Slide 16: Oh Canada! Growing Share & Expanding the Reach
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 6 Oh Canada! Growing Share & Expanding the Reach 10 Core Brands with Leading Positions Other(1) #2 #1 #1 #1 #1 #1 Supported by Focused Marketing for All Core OTC Brands Goal: Outperform category growth & introduce selected U
Slide 17: Q3 FY2014: Financial Overview
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 7 Q3 FY2014: Financial Overview
Slide 18: Summary Financial Performance
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 8 Summary Financial Performance Dollar values in millions, except per share data Notes: (1) These non-GAAP financial measures are reconciled to their most closely related GAAP financial measures in our earnings release in th
Slide 19: Q3 Consolidated Financial Summary
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 1 9 Q3 FY'14 Q3 FY'13 % Chg Net Revenue 146.2$ 160.2$ (8.7%) Adj. Gross Margin(1) 81.8 88.7 (7.8%) % Margin 56.0% 55.4% A&P 25.6 23.5 8.6% % Net Revenue 17.5% 14.7% G&A 12.1 11.4 6.7% % Net Revenue 8.3% 7.1% Adjusted EBITDA(1)
Slide 20: YTD Consolidated Financial Summary
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 0 Adjusted Net Revenue declined 2.5% over the prior year Adjusted gross margin expanded by 0.5 pts. to 57.0% A&P spend increased by 1.1 pts. to 15.5% of Adjusted Net Revenue Adjusted G&A as a percentage of Adjusted N
Slide 21: Net Income and E.P.S. Reconciliation
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 1 3 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended Q3 FY'14 Q3 FY'13 Q3 FY'14 Q3 FY'13 Net Income EPS Net Income EPS Net Income EPS Net Income EPS As Reported 3.1$ 0.06$ 12.3$ 0.24$ 56.6$ 1.08$ 46.2$ 0.90$ Adjustm
Slide 22: Strong Free Cash Flow
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 2 Q3 FY'14 Q3 FY'13 YTD FY'14 YTD FY'13 Net Income - As Reported 3.1$ 12.3$ 56.6$ 46.2$ Depreciation & Amortization 3.6 3.4 10.2 10.0 Other Non-Cash Operating Items 15.8 13.8 25.4 32.1 Working Capital 2.7 11.1 (11.4) 12.7 Pr
Slide 23: Prestige Continues to Have Leading Free Cash Flow Conversion
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 3 Prestige Continues to Have Leading Free Cash Flow Conversion Median: 107% Source: Capital IQ Notes: For the latest twelve month period. Free Cash Flow Conversion is a non GAAP financial measure and is defined as Non-GAAP O
Slide 24: Leading Free Cash Flow Yield Supports Attractive Valuation
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 4 Leading Free Cash Flow Yield Supports Attractive Valuation Source: Capital IQ Note: For the latest twelve month period. Free Cash Flow Yield is a non GAAP financial measure and is defined as Cash Provided by Operating Acti
Slide 25: FY2014 Outlook and Road Ahead
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 5 FY2014 Outlook and Road Ahead
Slide 26: Outlook for Q4 FY2014 and Beyond
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 6 Q4 Considerations: Remain Cautious Potential for continued soft retail and foot traffic and retailer inventory reductions Seasonal cough/cold incidences remain well below prior year Expect returning competitive brand
Slide 27: Our Corporate Mission
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 7 Our Corporate Mission To be the Best Mid-Sized, Public Company in the Consumer Health Care Market The following principles guide us in this endeavor: deliver outstanding shareholder value through superior growth in sales
Slide 28: P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 8
P R E S T I G E B R A N D S T h i r d Q u a r t e r F ’ 1 4 R e s u l t s 2 8
Prestige Brands Holdings — Q3 FY2014 Earnings Presentation on 6ix